BamSEC and AlphaSense Join Forces
Learn More

AN2 Therapeutics Inc. – Indentures

NASDAQ: ANTX    
Share price (7/2/26): $4.42    
Market cap (7/2/26): $159 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-3 52 pages AN2 Therapeutics, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.3
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 14 pages AN2 Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.1
from 8-K 14 pages AN2 Therapeutics, Inc. Form of Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.1
from 8-K 56 pages AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC as Rights Agent Rights Agreement Dated as of August 15, 2024 Rights Agreement
12/34/56
EX-4.9
from S-3 18 pages AN2 Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of AN2 Therapeutics, Inc. Form of Debt Securities Warrant Agreement Article 1
12/34/56
EX-4.8
from S-3 20 pages AN2 Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of AN2 Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.7
from S-3 20 pages AN2 Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of AN2 Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3 55 pages AN2 Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 83 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS 83 pages Amended and Restated Investors’ Rights Agreement
12/34/56